Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

TCR Repertoire Diversity Assessed with Immunosequencing Is Associated with Patient Mortality Following Cord Blood Transplant

Ryan O Emerson, PhD, Sarah Nikiforow, MD PhD, Filippo Milano, MD PhD, Anna M Sherwood, PhD, Adrienne Papermaster, Katherine A. Guthrie, PhD, Christopher S Carlson, PhD, Edus H. Warren, MD PhD, Jerome Ritz, MD, Harlan Robins, PhD, Corey S Cutler, MD MPH, Colleen Delaney, MD

Blood (2014) 124 (21): 1262.

https://doi.org/10.1182/blood.V124.21.1262.1262

Published: 2014

Journal Articles

Specific Features Identify Patients with Relapsed/Refractory Mantle Cell Lymphoma Benefitting From Autologous Hematopoietic Cell Transplantation.

Ryan D. Cassaday, MD, Katherine A. Guthrie, PhD, Lihua E. Budde, MD, PhD, Leslie Thompson, Brian G. Till, MD, Oliver W. Press, MD, PhD, Thomas Chauncey, MD, PhD, John M. Pagel, MD, PhD, Stephen H. Petersdorf, MD, William I. Bensinger, MD, Leona Holmberg, MD, PhD, Andrei R. Shustov, MD, Damian J. Green, MD, Edward N. Libby, III, MD, David G. Maloney, MD, PhD, Ajay K. Gopal, MD

Blood (2012) 120 (21): 3082.

https://doi.org/10.1182/blood.V120.21.3082.3082

Published: 2012

Journal Articles

T Cell Repertoire Diversity After Umbilical Cord Transplant Predicts Mortality From Infection

Colleen Delaney, MD, MSc, Ryan O Emerson, PhD, Filippo Milano, MD, PhD, Anna Sherwood, PhD, Adrienne Papermaster, Katherine A. Guthrie, PhD, Christopher S Carlson, PhD, Edus H. Warren, III, MD, PhD, Harlan Robins, PhD

Blood (2012) 120 (21): 4202.

https://doi.org/10.1182/blood.V120.21.4202.4202

Published: 2012

Journal Articles

Prognostic Factors On Outcome of Mantle Cell Lymphoma Patients Relapsing After Autologous Hematopoietic Stem Cell Transplantation.

Lihua E. Budde, MD, PhD, Katherine A Guthrie, PhD, Brian G. Till, MD, Thomas Chauncey, MD, Oliver W. Press, MD, PhD, John M. Pagel, MD, PhD, Stephen Petersdorf, William Bensinger, MD, Leona Holmberg, MD, PhD, Andrei R. Shustov, MD, David G Maloney, Ajay K. Gopal, MD

Blood (2009) 114 (22): 3327.

https://doi.org/10.1182/blood.V114.22.3327.3327

Published: 2009

Journal Articles

Apheresis Safety and Product Yield among Elderly Donors for Allogeneic Sibling Hematopoietic Cell Transplantation (HCT).

Ghada Abdalla, MD, Katherine A. Guthrie, PhD, Mohamed L. Sorror, MD,MSc, Michael Linenberger, MD

Blood (2006) 108 (11): 5223.

https://doi.org/10.1182/blood.V108.11.5223.5223

Published: 2006

Journal Articles

A Phase II Trial of 90 Y-Ibritumomab Tiuxetan-Based Reduced Intensity Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation for Relapsed CD20+ B-Cell Non-Hodgkins Lymphoma (NHL).

Ajay K. Gopal, MD, Joseph G. Rajendran, MD, John M. Pagel, MD, PhD, Katherine A. Guthrie, PhD, David G. Maloney, MD, PhD, Frederick R. Appelbaum, MD, Brenda M. Sandmaier, MD, Rainer F. Storb, MD, Oliver W. Press, MD, PhD

Blood (2006) 108 (11): 316.

https://doi.org/10.1182/blood.V108.11.316.316

Published: 2006

NARROW

TCR Repertoire Diversity Assessed with Immunosequencing Is Associated with Patient Mortality Following Cord Blood Transplant

Specific Features Identify Patients with Relapsed/Refractory Mantle Cell Lymphoma Benefitting From Autologous Hematopoietic Cell Transplantation.

T Cell Repertoire Diversity After Umbilical Cord Transplant Predicts Mortality From Infection

Prognostic Factors On Outcome of Mantle Cell Lymphoma Patients Relapsing After Autologous Hematopoietic Stem Cell Transplantation.

Apheresis Safety and Product Yield among Elderly Donors for Allogeneic Sibling Hematopoietic Cell Transplantation (HCT).

A Phase II Trial of 90 Y-Ibritumomab Tiuxetan-Based Reduced Intensity Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation for Relapsed CD20+ B-Cell Non-Hodgkins Lymphoma (NHL).

Email alerts

ASH Publications

American Society of Hematology

TCR Repertoire Diversity Assessed with Immunosequencing Is Associated with Patient Mortality Following Cord Blood Transplant

Specific Features Identify Patients with Relapsed/Refractory Mantle Cell Lymphoma Benefitting From Autologous Hematopoietic Cell Transplantation.

T Cell Repertoire Diversity After Umbilical Cord Transplant Predicts Mortality From Infection

Prognostic Factors On Outcome of Mantle Cell Lymphoma Patients Relapsing After Autologous Hematopoietic Stem Cell Transplantation.

Apheresis Safety and Product Yield among Elderly Donors for Allogeneic Sibling Hematopoietic Cell Transplantation (HCT).

A Phase II Trial of 90 Y-Ibritumomab Tiuxetan-Based Reduced Intensity Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation for Relapsed CD20+ B-Cell Non-Hodgkins Lymphoma (NHL).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only